Analysts' Actions: FDX TXN XOM LLY DHI

TheStreet.com

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Activision Blizzard ATVI rated new Outperform at Credit Suisse. $16 price target. Company can continue to expand around the globe.

Celgene CELG downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $86 price target. Company lacks near-term catalysts.

Check Point CHKP downgraded at Needham from Buy to Hold, Needham said. Recent field checks suggest that sales could slow down in the coming quarters.

Cott Corp COT rated new Buy at Citigroup. $10 price target. Strong EPS growth driven by a balance of factors.

Chevron CVX rated new Hold at Dahlman. Two major LNG projects add risk to the thesis.

DR Horton DHI downgraded at MKM from Buy to Neutral, MKM Partners said. Valuation call, as the sector has already made a big run.

Electronic Arts ERTS rated new Neutral at Credit Suisse. $16 price target. Company has struggled with its digital transition.

FedEx FDX upgraded at Standpoint from Hold to Buy, Standpoint said. $130 price target. Company is cutting costs and annual earnings can approach $10 a share.

Genomic Health GHDX rated new Neutral at Goldman. $36 price target. Company has limited earnings upside potential.

Host Hotels HST downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Expect slower industry RevPAR growth.

Johnson Controls JCI downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Management will struggle to turn the company around by 2013.

Lennar LEN downgraded at MKM from Buy to Neutral, MKM Partners said. See limited upside to near-term earnings expectations.

Marriott MAR downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Stock has outperformed the market year-to-date.

MetroPCS Communications PCS downgraded at Oppenheimer to Underperform from Perform, Oppenheimer said. Wireless to eventually consolidate into three players.

Rite Aid RAD rated new Buy at BTIG. $2.25 price target. Company is improving customer retention and margins.

Texas Instruments TXN downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $26 price target. Company is leveraged to slower macro growth.

Exxon Mobil XOM rated new Buy at Dahlman. $100 price target. Company will continue to buy back stock in the coming quarters.

Zynga ZNGA rated new Underperform at Credit Suisse. $3 price target. Company is losing customers, even for new games.

STOCK COMMENTS / EPS CHANGES

Adtran ADTN numbers lowered at Jefferies. Shares of ADTN now seen reaching $13.25, Jefferies said. Estimates also lowered on ugly Q3. Underperform rating.

Dean Foods DF numbers cut at UBS. Shares of DF now seen reaching $15.50, UBS said. Estimates also lowered on heightened dairy input cost pressure. Neutral rating.

FedEx FDX target raised at Citigroup to $108, Citigroup said. EBIT improvement target supports above consensus estimates. Buy rating.

IAC/InterActiveCorp IACI numbers raised at Oppenheimer. Shares of IACI now seen reaching $67, Oppenheimer said. Estimates also raised on numerous catalysts. Outperform rating.

Eli Lilly LLY target boosted at BofA/Merrill to $57, according to Bank of America/Merrill Lynch said. Sola should ultimately reach the market for Alzheimer's. Buy rating.

LyondellBasell LYB estimates raised at UBS through 2013, UBS said. Improved refining partially offsets weaker European OPO. Neutral rating and $49 price target.

Progressive PGR estimates, target raised at KBW. Shares of PGR now seen reaching $21, according to Keefe, Bruyette & Woods. Estimates also increased, given higher realized premium growth. Market Perform rating.

Universal Health UHS numbers raised at Credit Suisse. Shares of UHS now seen reaching $53, according to Credit Suisse. Estimates also increased, as the Ascend deal should add to earnings. Outperform rating.

Yum! Brands YUM numbers raised at UBS. Shares of YUM now seen reaching $84, UBS said. Estimates also increased on higher unit growth in China. Buy rating.

YUM! Brands numbers raised at Jefferies. Shares of YUM now seen reaching $70, Jefferies said. Estimates also raised on solid EPS beat. Hold rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

For less than $3 per week, you can get full access to Jim Cramer's intraday market commentary and stock trading strategies - sometimes before he says them on TV! Join now.

Rates

View Comments (1)